Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cell MedX's Enterprise Value is $6.78 Mil.
Cell MedX's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.03 Mil. Therefore, Cell MedX's EV-to-EBIT ratio for today is -233.86.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cell MedX's Enterprise Value is $6.78 Mil.
Cell MedX's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.03 Mil. Therefore, Cell MedX's EV-to-EBITDA ratio for today is -233.86.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cell MedX's Enterprise Value is $6.78 Mil.
Cell MedX's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was $0.00 Mil. Therefore, Cell MedX's EV-to-Revenue ratio for today is .
Cell MedX Enterprise Value Historical Data
The historical data trend for Cell MedX's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cell MedX's Enterprise Value
For the Medical Devices subindustry, Cell MedX's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell MedX's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cell MedX's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Cell MedX's Enterprise Value falls into.
Cell MedX Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Cell MedX's Enterprise Value for the fiscal year that ended in May. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell MedX (OTCPK:CMXC) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Cell MedX's current Enterprise Value is $6.78 Mil.
Cell MedX's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Cell MedX's current Enterprise Value is $6.78 Mil.
Cell MedX's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.
Cell MedX's current Enterprise Value is $6.78 Mil.
Cell MedX's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell MedX Enterprise Value Related Terms
Thank you for viewing the detailed overview of Cell MedX's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Cell MedX Corp is an early stage development company focused on the discovery, development and, commercialization of therapeutic products for patients with diseases such as diabetes, by developing technologies to help manage the illness and related complications. The company's product portfolio consists of electromedical technologies, ebalance, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CMXC has been successfully added to your 